Free Trial
NASDAQ:VRPX

Virpax Pharmaceuticals (VRPX) Stock Price, News & Analysis

Virpax Pharmaceuticals logo
$0.40 +0.05 (+14.71%)
As of 07/2/2025 03:15 PM Eastern

About Virpax Pharmaceuticals Stock (NASDAQ:VRPX)

Key Stats

Today's Range
$0.35
$0.44
50-Day Range
$0.22
$0.46
52-Week Range
$0.13
$84.75
Volume
4,271 shs
Average Volume
201,655 shs
Market Capitalization
$496.92 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$75.00
Consensus Rating
Hold

Company Overview

Virpax Pharmaceuticals Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
27th Percentile Overall Score

VRPX MarketRank™: 

Virpax Pharmaceuticals scored higher than 27% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Virpax Pharmaceuticals has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Virpax Pharmaceuticals has received no research coverage in the past 90 days.

  • Read more about Virpax Pharmaceuticals' stock forecast and price target.
  • Price to Book Value per Share Ratio

    Virpax Pharmaceuticals has a P/B Ratio of 0.24. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    0.67% of the float of Virpax Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Virpax Pharmaceuticals has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Virpax Pharmaceuticals has recently increased by 119.58%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Virpax Pharmaceuticals does not currently pay a dividend.

  • Dividend Growth

    Virpax Pharmaceuticals does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.67% of the float of Virpax Pharmaceuticals has been sold short.
  • Short Interest Ratio / Days to Cover

    Virpax Pharmaceuticals has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Virpax Pharmaceuticals has recently increased by 119.58%, indicating that investor sentiment is decreasing significantly.
  • Search Interest

    2 people have searched for VRPX on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Virpax Pharmaceuticals insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.70% of the stock of Virpax Pharmaceuticals is held by insiders.

  • Percentage Held by Institutions

    Only 32.23% of the stock of Virpax Pharmaceuticals is held by institutions.

  • Read more about Virpax Pharmaceuticals' insider trading history.
Receive VRPX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

VRPX Stock News Headlines

Virpax Pharmaceuticals Inc trading halted, news pending
"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
Virpax receives positive Probudur results for dose range study
Virpax Pharmaceuticals announces 1-for-25 reverse stock split
See More Headlines

VRPX Stock Analysis - Frequently Asked Questions

Virpax Pharmaceuticals' stock was trading at $9.4975 at the beginning of the year. Since then, VRPX stock has decreased by 95.8% and is now trading at $0.4001.
View the best growth stocks for 2025 here
.

Virpax Pharmaceuticals shares reverse split before market open on Friday, March 1st 2024.The 1-10 reverse split was announced on Friday, March 1st 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, March 1st 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Virpax Pharmaceuticals (VRPX) raised $15 million in an IPO on Wednesday, February 17th 2021. The company issued 1,400,000 shares at $10.00-$12.00 per share. ThinkEquity (a division of Fordham Financial Management) acted as the underwriter for the IPO.

Shares of VRPX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Virpax Pharmaceuticals investors own include AMC Entertainment (AMC), Dare Bioscience (DARE), Rallybio (RLYB), Mullen Automotive (MULN), Plug Power (PLUG), SNDL (SNDL) and SOS (SOS).

Company Calendar

Today
7/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:VRPX
Fax
N/A
Employees
7
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$75.00
High Stock Price Target
$75.00
Low Stock Price Target
$75.00
Potential Upside/Downside
+18,645.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.19 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$1.65 per share
Price / Book
0.24

Miscellaneous

Free Float
4,707,000
Market Cap
$496.92 thousand
Optionable
Not Optionable
Beta
1.49
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:VRPX) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners